Annual EPS
-$1.43
+$626.93+99.77%
01 December 2023
Summary:
Altamira Therapeutics annual earnings per share is currently -$1.43, with the most recent change of +$626.93 (+99.77%) on 01 December 2023. During the last 3 years, it has risen by +$577.04 (+99.75%). CYTO annual EPS is now at all-time high.CYTO EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EPS
N/A
01 June 2024
Summary:
Altamira Therapeutics quarterly earnings per share is not available.CYTO Quarterly EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EPS
N/A
01 June 2024
Summary:
Altamira Therapeutics TTM earnings per share is not available.CYTO TTM EPS Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYTO EPS Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +99.8% | - | - |
| 3 y3 years | +99.8% | - | - |
| 5 y5 years | +100.0% | - | - |
CYTO EPS High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +99.8% | ||||
| 5 y | 5 years | at high | +100.0% | ||||
| alltime | all time | at high | +100.0% |
Altamira Therapeutics EPS History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$1.43(-99.8%) | - | - |
| Dec 2022 | -$628.36(+11.5%) | - | - |
| Dec 2021 | -$563.52(-2.6%) | - | - |
| Dec 2020 | -$578.47(-38.5%) | - | - |
| Dec 2019 | -$941.24(-84.0%) | - | - |
| Dec 2018 | -$5874.82(-85.8%) | -$975.07(-14.6%) | -$8673.29(-45.5%) |
| Sept 2018 | - | -$1141.29(-71.8%) | -$15.91 K(-38.6%) |
| June 2018 | - | -$4040.05(+60.5%) | -$25.93 K(-19.2%) |
| Mar 2018 | - | -$2516.88(-69.4%) | -$32.11 K(-31.4%) |
| Dec 2017 | -$41.49 K(-40.9%) | -$8212.79(-26.4%) | -$46.79 K(-2.3%) |
| Sept 2017 | - | -$11.16 K(+9.2%) | -$47.88 K(-14.1%) |
| June 2017 | - | -$10.22 K(-40.5%) | -$55.76 K(-15.5%) |
| Mar 2017 | - | -$17.19 K(+84.7%) | -$65.95 K(-6.2%) |
| Dec 2016 | -$70.15 K | -$9307.14(-51.1%) | -$70.32 K(-3.6%) |
| Sept 2016 | - | -$19.04 K(-6.7%) | -$72.96 K(+9.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | -$20.41 K(-5.3%) | -$66.46 K(-11.9%) |
| Mar 2016 | - | -$21.55 K(+80.3%) | -$75.41 K(-2.1%) |
| Dec 2015 | -$74.46 K(+46.6%) | -$11.95 K(-4.6%) | -$77.00 K(-2.3%) |
| Sept 2015 | - | -$12.53 K(-57.3%) | -$78.80 K(+1.0%) |
| June 2015 | - | -$29.37 K(+26.9%) | -$78.04 K(+18.0%) |
| Mar 2015 | - | -$23.15 K(+68.3%) | -$66.12 K(+4.0%) |
| Dec 2014 | -$50.80 K(-3.5%) | -$13.75 K(+16.8%) | -$63.56 K(+1.1%) |
| Sept 2014 | - | -$11.78 K(-32.5%) | -$62.89 K(-6.7%) |
| June 2014 | - | -$17.45 K(-15.2%) | -$67.38 K(+2.2%) |
| Mar 2014 | - | -$20.58 K(+57.3%) | -$65.94 K(+25.2%) |
| Dec 2013 | -$52.67 K(+235.4%) | -$13.08 K(-19.6%) | -$52.67 K(+33.1%) |
| Sept 2013 | - | -$16.27 K(+1.6%) | -$39.59 K(+69.7%) |
| June 2013 | - | -$16.01 K(+119.0%) | -$23.32 K(+219.0%) |
| Mar 2013 | - | -$7309.94 | -$7309.94 |
| Dec 2012 | -$15.71 K | - | - |
FAQ
- What is Altamira Therapeutics annual earnings per share?
- What is the all time high annual EPS for Altamira Therapeutics?
- What is Altamira Therapeutics annual EPS year-on-year change?
- What is the all time high quarterly EPS for Altamira Therapeutics?
- What is the all time high TTM EPS for Altamira Therapeutics?
What is Altamira Therapeutics annual earnings per share?
The current annual EPS of CYTO is -$1.43
What is the all time high annual EPS for Altamira Therapeutics?
Altamira Therapeutics all-time high annual earnings per share is -$1.43
What is Altamira Therapeutics annual EPS year-on-year change?
Over the past year, CYTO annual earnings per share has changed by +$626.93 (+99.77%)
What is the all time high quarterly EPS for Altamira Therapeutics?
Altamira Therapeutics all-time high quarterly earnings per share is -$975.07
What is the all time high TTM EPS for Altamira Therapeutics?
Altamira Therapeutics all-time high TTM earnings per share is -$7309.94